Ai crispr
42-year-old with type 1 diabetes experienced a temporary return of insulin production after receiving transplanted lab-grown insulin-producing cells. The patient, who had lived with diabetes for nearly 40 years, had the cells implanted directly into his arm muscle. For 12 weeks, his body produced its own insulin following the transplant.
This procedure involved transplanting lab-grown beta cells, which are the type of cells that produce insulin in the pancreas. In type 1 diabetes, these cells are destroyed by the body's immune system, leading to a complete lack of insulin. Traditionally, islet cell transplantation, where islet cells from a deceased donor are transplanted into the liver, is used to treat type 1 diabetes. However, this new approach utilizes cells grown in a lab, offering a potential new avenue for treatment.
The 12-week period of insulin production in this patient is a promising sign, demonstrating the potential of this innovative therapy. Further research and development are needed to determine if this approach can lead to longer-term insulin independence for people with type 1 diabetes.
Comments
Post a Comment